Flinton Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Flinton Capital Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$481K	Sell	6,426 -1,870	-23%	-$159K	0.01%	465
2019 Q2	$669K	Buy	8,296 +544	+7%	+$38.2K	0.02%	406
2019 Q1	$519K	Buy	7,752 +1,326	+21%	+$100K	0.02%	450
2018 Q4	$478K	Hold	6,426	–	–	0.02%	433
2018 Q3	$592K	Buy	6,426 +1,394	+28%	+$133K	0.02%	445
2018 Q2	$495K	Hold	5,032	–	–	0.02%	434
2018 Q1	$561K	Hold	5,032	–	–	0.02%	398
2017 Q4	$518K	Buy	5,032 +884	+21%	+$88.1K	0.02%	417
2017 Q3	$391K	Buy	4,148 +578	+16%	+$45.6K	0.01%	445
2017 Q2	$278K	Buy	3,570 +1,496	+72%	+$112K	0.01%	506
2017 Q1	$166K	Sell	2,074 -68	-3%	-$5.4K	0.01%	531
2016 Q4	$169K	Buy	+2,142	New	+$166K	0.01%	491

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Flinton Capital Management's CMD Position: Q3 2019 in Review

Flinton Capital Management reduced its Cantel Medical Corporation (CMD) stake by 23% in Q3 2019, selling an estimated $159K and leaving 6,426 shares worth $481K. The position accounts for 0.01% of the portfolio, ranked #465.

Flinton Capital Management first reported a position in CMD in Q4 2016 and has held it in 12 quarters since. The position peaked at $669K in Q2 2019. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

Flinton Capital Management held 6,426 shares of Cantel Medical Corporation worth $481K as of Q3 2019.
Flinton Capital Management sold 1,870 Cantel Medical Corporation shares in Q3 2019, an estimated $159K.
Cantel Medical Corporation made up 0.01% of Flinton Capital Management's portfolio in Q3 2019, its #465 holding.
Flinton Capital Management first reported a position in Cantel Medical Corporation in Q4 2016 and has held it in 12 quarters since.
Flinton Capital Management's Cantel Medical Corporation position peaked at $669K in Q2 2019.
244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Flinton Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.